Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height

Sangamo BioSciences

Sangamo BioSciences reported $18.03M in Operating Profit for its fiscal quarter ending in March of 2023.


Operating Profit Change
Alaunos Therapeutics Inc ZIOP:US USD -9672000 1.15M
Alnylam Pharmaceuticals ALNY:US USD -149807000 38.81M
Amgen AMGN:US USD 2.03B 196M
Bayer BAYN:GR EUR 2.97B 1.54B
BioCryst Pharmaceuticals BCRX:US USD -28415000 17.9M
Biogen BIIB:US USD 507.7M 192.2M
BioMarin Pharmaceutical BMRN:US USD 59.35M 83.85M
Bluebird Bio BLUE:US USD 8.44M 17M
Gilead Sciences GILD:US USD 1.7B 562M
GlaxoSmithKline GSK:LN GBP 2.08B 215M
Intercept Pharmaceuticals ICPT:US USD -31632000 13.61M
Ionis Pharmaceuticals IONS:US USD -114148000 93.87M
J&J JNJ:US USD -737000000 4.94B
Karyopharm Therapeutics KPTI:US USD -30899000 2.97M
Merck & Co MRK:US USD 3.72B 286M
Novartis NOVN:VX USD 2.86B 907M
Pfizer PFE:US USD 6.79B 1.62B
Roche Holding ROG:VX CHF 5.93B 5.62B
Sangamo BioSciences SGMO:US USD 18.03M 73.43M
Sarepta Therapeutics SRPT:US USD -525417000 416.01M
Ultragenyx Pharmaceutical RARE:US USD -154105000 8.48M
Vertex Pharmaceuticals VRTX:US USD 779M 254.5M